Rhumbline Advisers Ocugen, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Ocugen, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 324,475 shares of OCGN stock, worth $181,706. This represents 0.0% of its overall portfolio holdings.
Number of Shares
324,475
Previous 287,441
12.88%
Holding current value
$181,706
Previous $284,000
8.8%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding OCGN
# of Institutions
123Shares Held
68.6MCall Options Held
478KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$10 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.6MShares$9.31 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.59MShares$3.69 Million0.0% of portfolio
-
State Street Corp Boston, MA5.87MShares$3.29 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.37 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $121M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...